IBKR Stock Charts

Quarterly

Annual

Unit: USD	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2010-06-30	2010-03-31	2009-03-31	2008-12-31	2007-06-30	2007-03-31

cash flows from operating activities
net income	1,186,000,000	1,006,000,000	964,000,000	969,000,000	834,000,000	809,000,000	795,000,000	739,000,000	772,000,000	601,000,000	700,000,000	633,000,000	483,000,000	360,000,000	366,000,000	338,000,000	206,000,000	506,000,000	586,000,000	380,000,000	302,000,000	207,000,000	290,000,000	294,000,000	261,000,000	210,000,000	324,000,000	290,000,000	258,000,000	258,000,000	319,000,000	247,000,000	187,000,000	195,000,000	168,000,000	200,000,000	310,000,000	31,690,000	160,758,000	201,194,000	185,968,000	120,036,000	75,288,000				64,768,000	59,687,000	155,115,000		-177,190,000	184,196,000
adjustments to reconcile net income to net cash from operating activities
deferred income taxes	20,000,000	9,000,000	-1,000,000	-9,000,000	1,000,000	7,000,000	-1,000,000	21,000,000	2,000,000	4,000,000	3,000,000	12,000,000	2,000,000	4,000,000	2,000,000	5,000,000	-11,000,000	14,000,000	15,000,000	-3,000,000	2,000,000	5,000,000	5,000,000	7,000,000	5,000,000	3,000,000	9,000,000	2,000,000	8,000,000	7,000,000	4,000,000	8,000,000	10,000,000	5,000,000	3,000,000	10,000,000	8,000,000	6,397,000	6,057,000	2,390,000	1,814,000	-409,000	9,759,000						11,348,000
depreciation and amortization	15,000,000	15,000,000	15,000,000	16,000,000	17,000,000	17,000,000	17,000,000	16,000,000	17,000,000	16,000,000	16,000,000	15,000,000	14,000,000	14,000,000	15,000,000	13,000,000	12,000,000	12,000,000	13,000,000	11,000,000	11,000,000	10,000,000	10,000,000	10,000,000	7,000,000	7,000,000	7,000,000	8,000,000	6,000,000	5,000,000	7,000,000	6,000,000	6,000,000	6,000,000	6,000,000	6,000,000	6,000,000	4,624,000	4,555,000	4,896,000	4,475,000	4,470,000	4,969,000						4,980,000		2,998,000	2,953,000
amortization of right-of-use assets	9,000,000	8,000,000	7,000,000	7,000,000	8,000,000	7,000,000	7,000,000	9,000,000	6,000,000	7,000,000	7,000,000	7,000,000	6,000,000	7,000,000	6,000,000	7,000,000	6,000,000	6,000,000	5,000,000	6,000,000	4,000,000	5,000,000	5,000,000	6,000,000	5,000,000	5,000,000	5,000,000
employee stock plan compensation	31,000,000	28,000,000	31,000,000	32,000,000	26,000,000	26,000,000	28,000,000	25,000,000	26,000,000	23,000,000	26,000,000	28,000,000	22,000,000	21,000,000	21,000,000	29,000,000	17,000,000	17,000,000	17,000,000	19,000,000	17,000,000	13,000,000	16,000,000	17,000,000	13,000,000	14,000,000	16,000,000	16,000,000	13,000,000	15,000,000	14,000,000	13,000,000	12,000,000	13,000,000	12,000,000	10,000,000	12,000,000	9,866,000	11,550,000	10,051,000	3,905,000	15,711,000	8,470,000						7,909,000
unrealized (gains) losses on other investments	-43,000,000	-16,000,000	-17,000,000	6,000,000	-13,000,000	-13,000,000	8,000,000	7,000,000	-28,000,000	10,000,000	-3,000,000
customer bad debt expense		1,000,000	1,000,000		7,000,000	2,000,000	5,000,000
shares distributed to customers under ibkr promotions	8,000,000	8,000,000	9,000,000	6,000,000	6,000,000	6,000,000	5,000,000	5,000,000	2,000,000	3,000,000	2,000,000	2,000,000	2,000,000	2,000,000	3,000,000	3,000,000	2,000,000	2,000,000	2,000,000
change in operating assets and liabilities
securities - segregated for regulatory purposes	-1,719,000,000	-7,578,000,000	-1,548,000,000	3,257,000,000	-2,785,000,000	974,000,000	6,094,000,000	-4,051,000,000			-5,206,000,000	-480,000,000	-592,000,000	-6,359,000,000	-9,229,000,000	-721,000,000	1,235,000,000	9,434,000,000	2,752,000,000	1,495,000,000	4,134,000,000	-3,263,000,000	-12,363,000,000	3,422,000,000	-973,000,000	-1,741,000,000	-2,937,000,000	-2,763,000,000	536,000,000	-615,000,000	932,000,000
securities borrowed	-1,423,000,000	-4,300,000,000	-476,000,000	2,144,000,000	-1,295,000,000	144,000,000	-527,000,000	-357,000,000	521,000,000	-693,000,000	-557,000,000	-841,000,000	-53,000,000	590,000,000	-533,000,000	-101,000,000	-181,000,000	2,078,000,000	-752,000,000	-961,000,000	841,000,000	-866,000,000	-54,000,000	94,000,000	18,000,000	168,000,000	-865,000,000	220,000,000	37,000,000	-620,000,000	-11,000,000	-300,000,000	28,000,000	-294,000,000	-1,025,000,000	251,000,000	-87,000,000
securities purchased under agreements to resell	1,005,000,000	-1,153,000,000	-1,801,000,000	1,601,000,000	-1,965,000,000	463,000,000	-1,170,000,000	-24,000,000	951,000,000	268,000,000	-670,000,000	-1,169,000,000	1,428,000,000	-20,000,000	-1,888,000,000	1,728,000,000	-1,942,000,000	-2,474,000,000	-900,000,000	609,000,000	-34,000,000	-457,000,000	2,201,000,000	-1,720,000,000	-89,000,000	278,000,000	-338,000,000	-911,000,000	202,000,000	144,000,000	1,358,000,000	-223,000,000			-35,000,000	692,000,000	-610,000,000
financial instruments owned, at fair value	731,000,000	-448,000,000	-1,480,000,000	1,027,000,000	-1,184,000,000	-653,000,000	376,000,000	-163,000,000	-828,000,000	-113,000,000	71,000,000	612,000,000	-537,000,000	18,000,000	96,000,000	-12,000,000	66,000,000	-82,000,000	-4,000,000	-170,000,000	436,000,000	316,000,000	704,000,000	-40,000,000	-689,000,000	136,000,000	803,000,000	467,000,000	-501,000,000	326,000,000	742,000,000	-5,000,000	450,000,000	1,014,000,000	434,000,000	-609,000,000	-260,000,000
receivables from customers	-12,242,000,000	-1,489,000,000	574,000,000	-8,427,000,000	-761,000,000	-3,859,000,000	-6,928,000,000	-875,000,000	-1,636,000,000	-2,473,000,000	-735,000,000	1,664,000,000	2,127,000,000	5,753,000,000	6,628,000,000	-4,432,000,000	-549,000,000	-7,310,000,000	-3,314,000,000	-8,989,000,000	-4,668,000,000	-5,589,000,000	11,205,000,000	-5,334,000,000	-64,000,000	-40,000,000	1,106,000,000	3,894,000,000	-1,942,000,000	494,000,000	354,000,000	-2,500,000,000	-1,561,000,000	-1,865,000,000	-3,089,000,000	82,000,000	1,828,000,000
other receivables	-733,000,000	-1,590,000,000	-296,000,000	-9,000,000	-320,000,000	-192,000,000	-103,000,000	148,000,000	-375,000,000	259,000,000	1,760,000,000	-265,000,000	-1,456,000,000	217,000,000	1,592,000,000	253,000,000	-60,000,000	-607,000,000	-2,126,000,000	1,286,000,000	-1,168,000,000	172,000,000	-805,000,000	157,000,000	-134,000,000	12,000,000	-31,000,000	116,000,000	288,000,000	-150,000,000	-162,000,000	112,000,000	-109,000,000	-17,000,000	579,000,000	-632,000,000	-22,000,000
other assets	-104,000,000	-149,000,000	-42,000,000	-68,000,000	-31,000,000	-69,000,000	-35,000,000	-44,000,000	-3,000,000	-31,000,000	-25,000,000	-26,000,000	26,000,000	55,000,000	-20,000,000	-179,000,000	-2,000,000	-11,000,000	-6,000,000	-7,000,000	-3,000,000	3,000,000	-4,000,000	-21,000,000	-3,000,000	-5,000,000	-140,000,000	4,000,000	21,000,000	-2,000,000	-12,000,000	-6,000,000
securities loaned	5,802,000,000	4,335,000,000	646,000,000	-570,000,000	1,136,000,000	1,466,000,000	2,869,000,000	865,000,000	221,000,000	-458,000,000	1,779,000,000	-550,000,000	-1,206,000,000	-683,000,000	-390,000,000	1,234,000,000	-1,045,000,000	-287,000,000	2,029,000,000	4,100,000,000	-118,000,000	1,812,000,000	-366,000,000	455,000,000	-146,000,000	-149,000,000	213,000,000	203,000,000	-257,000,000	-80,000,000	-273,000,000	500,000,000	-335,000,000	-326,000,000	347,000,000	869,000,000	-493,000,000
securities sold under agreement to repurchase															300,000,000					0	0	0	-1,909,000,000					0	0	0	-1,316,000,000
financial instruments sold, but not yet purchased, at fair value	5,000,000	242,000,000	-41,000,000	-88,000,000	-92,000,000	237,000,000	43,000,000	-5,000,000	41,000,000	-33,000,000	44,000,000	-265,000,000	193,000,000	28,000,000	8,000,000	-51,000,000	42,000,000	0	38,000,000	-34,000,000	-47,000,000	73,000,000	-296,000,000	-520,000,000	620,000,000	102,000,000	-426,000,000	-234,000,000	285,000,000	388,000,000	-525,000,000	203,000,000	-392,000,000	-779,000,000	-417,000,000	-87,000,000	353,000,000
payable to customers	11,025,000,000	17,763,000,000	5,311,000,000	2,764,000,000	9,206,000,000	2,176,000,000	185,000,000	6,139,000,000	-1,126,000,000	1,102,000,000	1,702,000,000	601,000,000	1,829,000,000	-332,000,000	5,463,000,000	1,549,000,000	2,635,000,000	248,000,000	5,322,000,000	7,052,000,000	34,000,000	6,057,000,000	6,491,000,000	1,774,000,000	1,420,000,000	2,312,000,000	2,749,000,000	-1,830,000,000	1,584,000,000	816,000,000	-125,000,000	1,600,000,000	1,649,000,000	2,570,000,000	3,167,000,000	929,000,000	1,306,000,000
other payables	14,000,000	447,000,000	728,000,000	-831,000,000	787,000,000	73,000,000	15,000,000	-84,000,000	294,000,000	98,000,000	160,000,000	3,000,000	118,000,000	76,000,000	-316,000,000	-92,000,000	603,000,000	-106,000,000	163,000,000	-160,000,000	77,000,000	-41,000,000	47,000,000	-35,000,000	-126,000,000	51,000,000	171,000,000	109,000,000	93,000,000	-55,000,000	-107,000,000	-201,000,000	267,000,000	-36,000,000	-63,000,000	-87,000,000	-31,000,000
net cash from operating activities	4,479,000,000	7,139,000,000	2,584,000,000	1,838,000,000	3,582,000,000	1,621,000,000	1,683,000,000	2,369,000,000	979,000,000	2,119,000,000	-923,000,000	-30,000,000	2,414,000,000	-541,000,000	2,125,000,000	-375,000,000	1,213,000,000	1,324,000,000	3,734,000,000	4,596,000,000	-174,000,000	-1,557,000,000	5,203,000,000	488,000,000	133,000,000	1,442,000,000	603,000,000	-408,000,000	632,000,000	931,000,000	1,201,000,000	73,000,000	509,000,000	-209,000,000	102,000,000	-110,000,000	122,000,000	242,989,000											56,682,000		187,870,000	216,644,000
capex	-15,000,000	-14,000,000	-16,000,000	-15,000,000	-11,000,000	-11,000,000	-12,000,000	-9,000,000	-8,000,000	-15,000,000	-17,000,000	-19,000,000	-18,000,000	-13,000,000	-19,000,000	-26,000,000	-13,000,000	-17,000,000	-21,000,000	-19,000,000	-9,000,000	-10,000,000	-12,000,000	-12,000,000	-17,000,000	-19,000,000	-26,000,000	-13,000,000	-8,000,000	-7,000,000	-8,000,000	-6,000,000	0	0	-7,000,000	0	0	-4,417,000											-4,991,000		0	0
free cash flows	4,464,000,000	7,125,000,000	2,568,000,000	1,823,000,000	3,571,000,000	1,610,000,000	1,671,000,000	2,360,000,000	971,000,000	2,104,000,000	-940,000,000	-49,000,000	2,396,000,000	-554,000,000	2,106,000,000	-401,000,000	1,200,000,000	1,307,000,000	3,713,000,000	4,577,000,000	-183,000,000	-1,567,000,000	5,191,000,000	476,000,000	116,000,000	1,423,000,000	577,000,000	-421,000,000	624,000,000	924,000,000	1,193,000,000	67,000,000	509,000,000	-209,000,000	95,000,000	-110,000,000	122,000,000	238,572,000											51,691,000		187,870,000	216,644,000
cash flows from investing activities
purchases of other investments	-29,000,000	-28,000,000	-10,000,000	-12,000,000	-24,000,000	-3,000,000	-1,000,000	-16,000,000				0	-2,000,000			-103,000,000	-9,000,000	-3,000,000	-1,000,000	-3,000,000	0			0	0	-3,000,000	-16,000,000	-1,000,000	0									-346,855,000
purchase of property, equipment and intangible assets	-15,000,000	-14,000,000	-16,000,000	-15,000,000	-11,000,000	-11,000,000	-12,000,000	-9,000,000	-8,000,000	-15,000,000	-17,000,000	-19,000,000	-18,000,000	-13,000,000	-19,000,000	-26,000,000	-13,000,000	-17,000,000	-21,000,000	-19,000,000	-9,000,000	-10,000,000	-12,000,000	-12,000,000	-17,000,000	-19,000,000	-26,000,000	-13,000,000	-8,000,000	-7,000,000	-8,000,000	-6,000,000
net cash from investing activities	-44,000,000	-42,000,000	-26,000,000	18,000,000	-35,000,000	-14,000,000	-13,000,000	-25,000,000	-18,000,000	-15,000,000	6,000,000	-19,000,000	-22,000,000	-12,000,000	-14,000,000	-129,000,000	-21,000,000	-17,000,000	-21,000,000	-22,000,000	-5,000,000	-12,000,000	-11,000,000	-12,000,000	-15,000,000	-20,000,000	-42,000,000	-14,000,000	-7,000,000	-28,000,000	-8,000,000	-4,000,000			-7,000,000	-5,000,000	23,000,000	-151,722,000	128,031,000	87,486,000	-21,413,000	25,668,000	7,104,000						-11,426,000
cash flows from financing activities
short-term borrowings	2,000,000	-4,000,000	-2,000,000	-19,000,000	22,000,000	-3,000,000	-3,000,000	6,000,000	-6,000,000	7,000,000	-8,000,000	-17,000,000	18,000,000	6,000,000	-16,000,000	-2,000,000	-145,000,000	161,000,000	-10,000,000	-606,000,000	489,000,000	125,000,000	-2,000,000	1,000,000	0			-11,000,000	-165,000,000	174,000,000	4,000,000	29,000,000	-29,000,000	-36,000,000	16,000,000	4,000,000	4,000,000
dividends paid to stockholders	-36,000,000	-35,000,000	-27,000,000	-27,000,000	-27,000,000	-27,000,000	-11,000,000	-11,000,000	-10,000,000	-11,000,000	-10,000,000	-10,000,000	-10,000,000	-11,000,000	-9,000,000	-10,000,000	-10,000,000	-9,000,000	-9,000,000	-9,000,000	-8,000,000	-7,000,000	-8,000,000	-8,000,000	-8,000,000			-7,000,000	-8,000,000	-7,000,000	-7,000,000	-7,000,000			-7,000,000			-5,710,000
distributions to noncontrolling interests	-196,000,000	-288,000,000	-196,000,000	-139,000,000	-172,000,000	-281,000,000	-123,000,000	-103,000,000	-111,000,000	-223,000,000	-119,000,000																			-189,000,000	-61,000,000	-140,000,000	-48,000,000	-34,000,000	-24,000,000	-125,000,000	-35,000,000	-40,657,000
repurchases of common stock for employee tax withholdings	0			0	0			0	0
proceeds from the sale of treasury stock	0			-1,000,000	0			0	0			0	0			0	0			0	0			0	0			0	0			0
payments made under the tax receivable agreement	0			0	0			0	0			0	0							0	0			0				0	0						0			0
net cash from financing activities	-230,000,000	-331,000,000	-225,000,000	-186,000,000	-177,000,000	-333,000,000	-137,000,000	-108,000,000	-127,000,000	-252,000,000	-137,000,000	-122,000,000	-70,000,000	-173,000,000	-105,000,000	-174,000,000	-506,000,000	158,000,000	-1,000,000	-555,000,000	416,000,000	-27,000,000	-63,000,000	-61,000,000	-242,000,000	-46,000,000	-70,000,000	-58,000,000	-222,000,000	-55,000,000	-64,000,000	-133,000,000	-84,000,000	-77,000,000	10,000,000	-170,000,000	-38,000,000	-2,198,000											-278,914,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	-38,000,000	306,000,000	107,000,000	-248,000,000	153,000,000	-10,000,000	-102,000,000	148,000,000	-76,000,000	31,000,000	19,000,000	158,000,000	-123,000,000	-105,000,000	-41,000,000	-2,000,000
net increase in cash, cash equivalents and restricted cash	4,167,000,000	7,072,000,000	2,440,000,000	1,422,000,000	3,523,000,000	1,264,000,000	1,431,000,000	2,384,000,000	758,000,000	1,883,000,000	-1,035,000,000	-13,000,000	2,199,000,000	-831,000,000	1,965,000,000	-680,000,000
cash, cash equivalents and restricted cash at beginning of period	0	0	40,233,000,000	0	0	0	32,593,000,000	0	0	0	28,603,000,000	0	0	0	25,283,000,000	0
cash, cash equivalents and restricted cash at end of period	4,167,000,000	7,072,000,000	42,673,000,000	1,422,000,000	3,523,000,000	1,264,000,000	34,024,000,000	2,384,000,000	758,000,000	1,883,000,000	27,568,000,000	-13,000,000	2,199,000,000	-831,000,000	27,248,000,000	-680,000,000
cash, cash equivalents and restricted cash
cash and cash equivalents	440,000,000	1,188,000,000	3,500,000,000	38,000,000	-323,000,000	-145,000,000	4,063,000,000	-71,000,000	143,000,000	467,000,000	3,214,000,000	252,000,000	303,000,000	214,000,000	2,667,000,000	-443,000,000	-380,000,000	591,000,000	2,627,000,000	1,000,000,000	177,000,000	14,000,000	3,101,000,000	-153,000,000	-127,000,000	616,000,000	2,546,000,000	-465,000,000	562,000,000	599,000,000	1,901,000,000
cash segregated for regulatory purposes	3,727,000,000	5,884,000,000	39,173,000,000	1,384,000,000	3,846,000,000	1,409,000,000	29,961,000,000	2,455,000,000	615,000,000	1,416,000,000	24,354,000,000	-265,000,000	1,896,000,000	-1,045,000,000	24,581,000,000	-237,000,000	1,026,000,000	895,000,000	21,204,000,000	3,114,000,000	105,000,000	-1,588,000,000	14,272,000,000	606,000,000	-25,000,000	776,000,000	8,043,000,000	-20,000,000	-163,000,000	171,000,000	7,515,000,000
supplemental disclosures of cash flow information
cash paid for interest	1,101,000,000	1,044,000,000	963,000,000	1,071,000,000	1,079,000,000	1,034,000,000	1,006,000,000	942,000,000	891,000,000	818,000,000	666,000,000	452,000,000	248,000,000	83,000,000	50,000,000	57,000,000	50,000,000	36,000,000	79,000,000	52,000,000	45,000,000	58,000,000	129,000,000	139,000,000	188,000,000	169,000,000	158,000,000	136,000,000	113,000,000	106,000,000	89,000,000	59,000,000	47,000,000	30,000,000	21,000,000	17,000,000	18,000,000	22,761,000	11,102,000	13,788,000	11,845,000	14,356,000	14,460,000	15,002,000	17,581,000	18,585,000	17,619,000	16,571,000
cash paid for taxes	58,000,000	153,000,000	40,000,000	66,000,000	61,000,000	120,000,000	32,000,000	66,000,000	37,000,000	75,000,000	50,000,000	59,000,000	24,000,000	49,000,000	16,000,000	27,000,000	44,000,000	19,000,000	24,000,000	21,000,000	22,000,000	6,000,000	15,000,000	10,000,000	14,000,000	15,000,000	12,000,000	15,000,000	9,000,000	13,000,000	13,000,000	14,000,000	10,000,000	7,000,000	11,000,000	1,000,000	5,000,000	5,677,000	-5,707,000	26,533,000	8,270,000	16,345,000	20,628,000	6,890,000	12,223,000	6,239,000	52,383,000	8,276,000
cash paid for amounts included in lease liabilities	10,000,000	11,000,000	10,000,000	8,000,000	11,000,000	8,000,000	12,000,000	9,000,000	9,000,000	8,000,000	9,000,000	9,000,000	7,000,000	8,000,000	8,000,000	6,000,000	6,000,000	6,000,000	6,000,000	5,000,000	6,000,000	5,000,000	5,000,000	5,000,000	5,000,000	5,000,000	5,000,000
non-cash financing activities
issuance of common stock in exchange of member interests in ibg llc				0				0				0				0				557,000,000				0				0
redemption of member interests from ibg holdings llc				0				0				0				0				-557,000,000				0				0
adjustments to additional paid-in capital for changes in proportionate ownership in ibg llc	0	45,000,000	1,000,000	1,000,000	2,000,000	37,000,000	1,000,000	1,000,000	0	30,000,000	2,000,000	1,000,000	0	25,000,000	1,000,000	1,000,000	0	23,000,000	1,000,000	0	0			0	0			0	0			0			0			1,089,000	26,739,000	393,000	637,000
adjustments to noncontrolling interests for changes in proportionate ownership in ibg llc	0	-45,000,000	-1,000,000	-1,000,000	-2,000,000	-37,000,000	-1,000,000	-1,000,000	0	-30,000,000	-2,000,000	-1,000,000	0	-25,000,000	-1,000,000	-1,000,000	0	-23,000,000	-1,000,000	0	0			0	0			0	0			0			0			-1,089,000					125,000
(gain) loss on remeasurement of tax receivable agreement liability
bad debt expense								5,000,000	0	-1,000,000	3,000,000	0	1,000,000	1,000,000	1,000,000	0	0	1,000,000	2,000,000	0	3,000,000	3,000,000	7,000,000	-1,000,000	-2,000,000	4,000,000	43,000,000	2,000,000	-1,000,000	0	3,000,000	0	1,000,000	1,000,000	3,000,000			1,491,000	270,000	743,000
impairment loss												0								1,000,000				0	0			0	0	0	1,000,000	0
distributions received and proceeds from sales of other investments								0	0	0	23,000,000	0	-2,000,000	4,000,000	5,000,000	0	1,000,000	3,000,000	1,000,000	0	4,000,000	0	1,000,000	0	2,000,000			0							0	2,000,000	36,000,000
non-cash distributions to noncontrolling interests																												0
gain on remeasurement of tax receivable agreement liability
issuances of senior notes																0	191,000,000	635,000,000	602,000,000
redemptions of senior notes																0	-443,000,000	-583,000,000	-498,000,000																														-106,668,000
securities – segregated for regulatory purposes
unrealized (gain) loss on other investments												-5,000,000						-117,000,000	-108,000,000	-42,000,000	-10,000,000	-17,000,000	19,000,000	14,000,000	10,000,000	74,000,000	-106,000,000				-2,000,000
distributions from ibg llc to noncontrolling interests												-95,000,000	-78,000,000	-151,000,000	-80,000,000	-144,000,000	-99,000,000	-45,000,000	-86,000,000	-36,000,000	-65,000,000	-129,000,000	-53,000,000	-54,000,000	-205,000,000	-38,000,000	-60,000,000	-40,000,000
repurchases of common stock for employee tax withholdings under stock incentive plans												0	0			0	0			0	0			0	0			0	0			0			0
unrealized gain on other investments
effect of exchange rate changes on cash, cash equivalents, and restricted cash																		21,000,000	-76,000,000	95,000,000	45,000,000	22,000,000	-38,000,000	38,000,000	-28,000,000			-5,000,000	-4,000,000	-78,000,000	8,000,000
net increase in cash, cash equivalents, and restricted cash																		1,486,000,000	3,636,000,000	4,114,000,000	282,000,000	-1,574,000,000	5,091,000,000	453,000,000	-152,000,000	1,392,000,000	489,000,000	-485,000,000	399,000,000	770,000,000	1,137,000,000
cash, cash equivalents, and restricted cash at beginning of period																		0	20,195,000,000	0	0	0	12,282,000,000	0	0	0	10,100,000,000	0	0	0	8,279,000,000
cash, cash equivalents, and restricted cash at end of period																		1,486,000,000	23,831,000,000	4,114,000,000	282,000,000	-1,574,000,000	17,373,000,000	453,000,000	-152,000,000	1,392,000,000	10,589,000,000	-485,000,000	399,000,000	770,000,000	9,416,000,000
cash, cash equivalents, and restricted cash
securities sold under agreements to repurchase
unrealized loss on other investments
non-cash financing activities:
cash and securities - segregated for regulatory purposes																																621,000,000	523,000,000	-693,000,000	7,000,000	-1,749,000,000	-2,199,000,000
effect of exchange rate changes on cash and cash equivalents																																5,000,000	38,000,000	23,000,000	2,000,000	-19,000,000	39,000,000	-77,940,000	11,030,000	3,488,000						23,428,000		3,295,000	-6,347,000
net increase in cash and cash equivalents																																-59,000,000	459,000,000	-269,000,000			146,000,000										260,823,000	43,661,000	-240,005,000
cash and cash equivalents at beginning of period																																0	0	1,925,000,000	0	0	1,601,000,000	0	0	1,213,241,000	0	0	1,614,592,000	0	0	1,695,495,000	0	806,560,000	943,497,000		0	669,271,000
cash and cash equivalents at end of period																																-59,000,000	459,000,000	1,656,000,000	107,000,000	-304,000,000	1,747,000,000	11,129,000	8,191,000	991,439,000	133,671,000	229,981,000	1,184,868,000	-344,000,000	452,106,000	1,551,399,000	260,823,000	850,221,000	703,492,000		260,810,000	607,776,000
non-cash distribution to noncontrolling interests
purchase of property and equipment																																			-7,000,000			-4,417,000											-4,991,000
excess tax benefit on stock incentive plans
net decrease in cash and cash equivalents																																						11,129,000
unrealized losses on other investments																																					4,000,000
cash flows from operating activities:
adjustments to reconcile net income to net cash provided by
losses (gains) on other investments																																						5,399,000
change in operating assets and liabilities:
increase in cash and securities - segregated for regulatory purposes																																						225,733,000											-456,225,000
increase in securities borrowed																																						544,177,000
decrease (increase) in securities purchased under agreements to resell																																						785,000	8,427,000	103,568,000
decrease in financial instruments owned, at fair value
increase in receivables from customers																																						-1,935,988,000											-258,417,000
increase in other receivables
decrease in other assets
decrease in financial instruments sold, but not yet purchased, at fair value
increase in securities loaned																																						183,991,000	1,182,000	367,569,000	-273,714,000	269,885,000	358,227,000						74,884,000
increase in payable to customers																																						1,554,977,000	1,435,530,000	656,152,000	1,854,447,000	-106,002,000	1,638,930,000						708,102,000		1,149,004,000	677,017,000
decrease in other payables																																																	-295,037,000
cash flows from investing activities:
proceeds from sales of other investments																																						199,550,000	145,499,000	152,561,000	45,711,000	89,300,000	67,234,000
distributions received from and redemptions of equity investments																																						0			0
cash flows from financing activities:
increase in short-term borrowings																																								8,968,000									51,809,000
supplemental disclosures of cash flow information:
adjustments to reconcile net income to net cash from operating activities:
decrease in financial instruments owned																																									-11,066,000
decrease (increase) in other receivables
increase in other assets																																																	-7,219,000
decrease in financial instruments sold but not yet purchased
increase in other payables																																																			493,791,000	639,544,000
decrease in short-term borrowings
(gains) losses on other investments
decrease (increase) in financial instruments owned																																								1,020,583,000
increase in financial instruments sold but not yet purchased																																								16,879,000			76,519,000
dividends paid to shareholders
dividends paid to noncontrolling interests
translation losses																																									14,496,000	4,529,000	814,000
bad debt expense and other																																									1,129,000	889,000	454,000						725,000
increase in securities purchased under agreements to resell
decrease in other receivables																																											28,323,000						677,100,000
decrease (increase) in other assets
changes in redemption value of redeemable noncontrolling interests
changes to total equity (deficit) for the change in the redemption value of redeemable noncontrolling interests
see accompanying notes to the unaudited condensed consolidated financial statements.
adjustments to reconcile net income to net cash used in
operating activities:
losses on other investments																																											133,000
increase in financial instruments owned
distribution received from equity investment																																											11,054,000						1,130,000
adjustments to additional paid in capital for changes in proportionate ownership in ibg llc
adjustments to non-controlling interests for changes in proportionate ownership in ibg llc																																														38,000
adjustments to reconcile net income to net cash from operating
activities:
cash from operating activities
cash from investing activities
cash from financing activities
effect of exchange rate changes on cash
and cash equivalents
decrease in cash and cash equivalents
translation (gains) losses																																																	-34,745,000
losses on non-trading investments																																																	636,000
decrease in securities borrowed																																																	2,370,088,000
decrease in securities purchased under agreements to resell																																																	311,844,000			97,740,000
decrease in trading assets																																																	308,237,000
decrease in trading liabilities																																																	-3,522,643,000
(purchase) sale of investments																																																	-7,565,000
dividends paid to ibg holdings llc																																																	-33,781,000
reduction in non-controlling interest in subsidiary																																																	22,000
issuance of senior notes																																																	109,704,000		110,911,000	112,816,000
borrowings under senior secured credit facility
repayments of senior secured credit facility																																																	-300,000,000
interest paid																																																	20,860,000		140,926,000	134,178,000
taxes paid																																																	68,664,000		-3,994,000	5,279,000
increase in cash and cash equivalents
translation gains
minority interest
losses (gains) on non-trading investments
other																																																			468,000	29,000
decrease (increase) in trading assets																																																			-75,260,000	1,162,118,000
increase in trading liabilities
decrease in securities loaned
sale (purchase) of investments
puchase of ibg llc historical member interests
puchase of trading rights
net proceeds from issuance of class a and class b common stock
class a common stock acquired from employees
dividends paid by ibg llc prior to ipo
dividends paid to ibg holdings llc subsequent to ipo
cash capital contribution to the
ipo related transactions
deferred tax asset arising from ipo
payable to affiliate
net tax benefit retained, recorded as additional paid in capital
non-cash investing activities:
refinancing of bridge loan
(gains) losses on non-trading investments
decrease (increase) in securities borrowed
increase in trading assets
purchase of ibg llc historical member interests
distributions received from investment in exchange
(purchase) sale of trading rights
dividends paid by ibg llc prior to may 4, 2007
dividends paid to ibg holdings llc after may 3, 2007
members’ contributions to ibg llc
ibg llc member interests redeemed
adjustments to reconcile net income to net cash from in operating activities:
purchase of investments
dividends received from ibg llc
redemptions from senior notes
ibg llc member interests redeeemed
loss (income) from equity investments in exchanges																																																				591,000
increase in cash and securities — segregated for regulatory
increase in securities sold under agreements to repurchase																																																				17,093,000
members’ contributions
members’ interests redeeemed
dividends paid
refinancing of bridge loan receivable																																																				10,018,000

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.